Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Vantage Oncology received early financing of $9.0M on 2002-11-06.
| Series | Round size | Date |
|---|---|---|
| Series A | $9M | 11/2002 |
| Series B | $15M | 06/2004 |
| Series C | $22M | 05/2005 |
| Series C | $6M | 08/2006 |
| Series D | $22.5M | 02/2007 |
| Investors | Security type |
|---|---|
| Versant Ventures | Series A |
| Salix Ventures | Series A |
| CONNING CAPITAL PARTNERS | Series A |
| New Enterprise Associates (NEA) | Series B |
| Versant Ventures | Series B |
| Salix Ventures | Series B |
| CONNING CAPITAL PARTNERS | Series B |
| New Enterprise Associates (NEA) | Series C |
| Versant Ventures | Series C |
| Salix Ventures | Series C |
| CONNING CAPITAL PARTNERS | Series C |
| CCP Equity Partners | Series C |
| New Enterprise Associates (NEA) | Series C |
| Versant Ventures | Series C |
| Salix Ventures | Series C |
| Camden Partners | Series D |
| New Enterprise Associates (NEA) | Series D |
| Versant Ventures | Series D |
| Salix Ventures | Series D |
| CONNING CAPITAL PARTNERS | Series D |
Vantage Oncology's top competitor, Cancer Treatment Centers of America, earned an annual revenue of $1.1B.
Vantage Oncology's smallest competitor is Medical Practice with revenue of $470.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| 21st Century Oncology | $43,977 | $6.4M | 50 | - |
| US Oncology Holdings Inc | $49,516 | $140.0M | 4,800 | 561 |
| Oncure Medical | $70,509 | $8.5M | 150 | - |
| Riverbend Medical Group | $47,363 | $240.0M | 800 | 1 |
| North American Partners in Anesthesia | $52,348 | $88.0M | 420 | 252 |
| Cancer Treatment Centers of America | $44,652 | $1.1B | 7,500 | 84 |
| Medical Practice | $46,281 | $470,000 | 50 | 1 |
| Physician Partners of America | $44,787 | $650,000 | 77 | 55 |
| Fort Wayne Medical Oncology & Hematology | $44,669 | $14.0M | 100 | - |
| IncreMedical | $45,133 | $23.2M | 100 | - |
Zippia gives an in-depth look into the details of Vantage Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vantage Oncology. The employee data is based on information from people who have self-reported their past or current employments at Vantage Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vantage Oncology. The data presented on this page does not represent the view of Vantage Oncology and its employees or that of Zippia.
Vantage Oncology may also be known as or be related to Vantage Oncology and Vantage Oncology LLC.